Issues and Challenges of Iraqi pharmaceutical industries..Part 1 (public Sector)

Related Articles

 

Issues and Challenges of Iraqi pharmaceutical industries

in

public Sector

Dr. Fadi Hasan Jaber

IFPMC – London

2021 July 

 

 

 Abstract:

The study depend on scientific-analytical-statistical method in order to achieve goals, including most important obstacles and challenges that facing public pharmaceutical industries in Iraq. Which suffers from many crises and plans are incomplete or there are no strategies to develop this sector, which is considered most growing sector by number of its people Iraq today is 40 million. In addition, it is likely to reach 50 million in 2030, with an increase of one million people every year. The local production of the public sector does not represent only 5% of the total consumption. Here study shows volume of local production for public sector and what types of medicines it provides and geographical locations of these laboratories. The study also shows most important investment opportunities in public sector geographically and most prominent of these institutions (General Company for manufacture of medicines and medical supplies in Samarra (SDI), General Company for the manufacture of medicines and medical supplies in Nineveh (NDI), Baghdad factory for  manufacture of medical gases and pharmaceutical glass). The most important obstacles, conclusions and recommendations are to encourage foreign and local investors to invest in various industrial branches, by providing concessions and facilities, especially investment in small industries, paying attention to manufacturing industry in order to increase its contribution to the gross domestic product with extractive industry. Relying on industrial experiences in developing clear strategies that are compatible with the industrial reality and applying them on ground. Paying attention to infrastructure supporting industrial sector, reducing environmental pollutants in some industries through use of modern and internationally advanced equipment, increasing industrial investments, especially investment in security-stable areas, as well as speeding up the follow-up and implementation of the strategic paragraphs proposed by Ministry of Industry and Minerals in various industrial branches.

Keywords: pharmaceutical industries, public sector, Iraq

Click Here :

اشكالات وتحديات الصناعات الدوائية في القطاع العام بالعراق

Comments

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular stories

  قمة مجموعة العشرين G20 ..صعوبات اعادة بناء الاقتصاد الدولي

        قمة مجموعة العشرين G20 ..صعوبات اعادة بناء الاقتصاد الدولي د.رنا خالد  رئيسة الباحثين في منتدى صنع السياسات            للمرة الاولى في التاريخ تنعقد قمة مجموعة العشرين...

قمة مجموعة السبع ..تجمع الديمقراطيات الكبرى

بيان رأي قمة مجموعة السبع تجمع الديمقراطيات الكبرى د.رنا خالد  رئيسة الباحثين في منتدى صنع السياسات العامة  IFPMC-LONDON JUNE 2022 قمةُ قادةِ مجموعة السبع كانت خلال السنوات الماضية متهمة بأنها...